Key result
Angiotensin 1-7 pathway activation reduces inflammation and oxidative stress to potentially provide neuroprotection.
Why the study?
Current treatments for neurocognitive disorders have limited efficacy and focus on symptom attenuation, creating a need for therapies targeting underlying inflammatory and oxidative mechanisms.
Targeting the Ang-(1-7) axis of the renin-angiotensin system represents a promising strategy to counteract neuroinflammation and oxidative stress in aging and neurocognitive disorders.
Answers are grounded in this paper and cite their sources.
May support Ang-(1-7) targeting in neurocognitive disorders; hypothesis-generating and requires randomized trials before practice change.
Cognition broadly refers to the ability to perform mental processes such as learning and memory, attention, emotional awareness, and higher-order thinking. Cognitive deficits can result from the normal aging process or other factors such as disease progression or injury. While the exact etiology is not fully understood, emerging evidence suggests that enhanced inflammatory and oxidative stress processes during aging can dramatically decrease cognitive function in older adults, as well as contribute to the onset and progression of neurocognitive disorders. Current treatments for neurocognitive disorders have limited efficacy and typically focus on symptom attenuation rather than targeting intrinsic pathophysiology. With the rising aging population, there is a critical need to identify novel treatment approaches that target the underlying inflammatory and oxidative mechanisms contributing to neurocognitive disorders. In this regard, the renin-angiotensin system (RAS) may provide an ideal target, as this hormonal system has been implicated in the regulation of inflammatory and oxidative responses to impact cognitive functions. While most research to date has focused on the deleterious role of angiotensin (Ang) II pathways in age-related cognitive decline and neurocognitive disorders, more recent evidence has examined the potential for targeting Ang-(1-7), a protective hormone of the RAS, to counteract these effects. This review highlights emerging evidence showing that activation of Ang-(1-7) pathways reduces inflammation and oxidative stress and may provide a novel target to improve cognitive function and elicit neuroprotection, in the context of both aging and neurocognitive disorders.
No takes yet. Share an insight, caveat, or question.
Lucas et al. (2025) conducted a review in Neurocognitive disorders and aging. Angiotensin-(1-7) targeted therapies was evaluated. Activation of Angiotensin-(1-7) pathways reduces inflammation and oxidative stress, providing a potential novel therapeutic target to improve cognitive function and elicit neuroprotection.
Synapse has enriched 10 related papers. Consider them for comparative context: